The association between serum uric acid and residual β -cell function in type 2 diabetes

Journal of Diabetes Research

Volumn 2014, Issue , 2014, Pages

  Tang, Wei ^a   Fu, Qi ^b   Zhang, Qingqing ^b   Sun, Min ^b   Gao, Yuan ^a   Liu, Xuan ^b   Qian, Li ^b   Shan, Shan ^b   Yang, Tao ^b  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MATSUDA INSULIN SENSITIVITY INDEX; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; ANALYSIS; BLOOD; CYTOLOGY; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICAL MODEL; TIME;

AGED; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LINEAR MODELS; MALE; MIDDLE AGED; TIME FACTORS; URIC ACID;

EID: 84902153331     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2014/709691     Document Type: Article

References (31)

1. Ishizaka N., Ishizaka Y., Toda E.-I., Nagai R., Yamakado M., Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 5 1038 1044 2-s2.0-18244372463 10.1161/01.ATV.0000161274.87407.26 (Pubitemid 40627852)
2. Hwang I.-C., Suh S.-Y., Suh A.-R., Ahn H.-Y., The relationship between normal serum uric acid and nonalcoholic fatty liver disease. Journal of Korean Medical Science 2011 26 3 386 391 2-s2.0-79953734064 10.3346/jkms.2011.26.3.386
3. Ford E. S., Li C., Cook S., Choi H. K., Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007 115 19 2526 2532 2-s2.0-34248598108 10.1161/CIRCULATIONAHA.106.657627 (Pubitemid 46763226)
4. Dehghan A., van Hoek M., Sijbrands E. J. G., Hofman A., Witteman J. C. M., High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008 31 2 361 362 2-s2.0-38949120144 10.2337/dc07-1276 (Pubitemid 351213351)
5. Chien K.-L., Chen M.-F., Hsu H.-C., Chang W.-T., Su T.-C., Lee Y.-T., Hu F. B., Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clinical Chemistry 2008 54 2 310 316 2-s2.0-39749159736 10.1373/clinchem.2007. 095190 (Pubitemid 351302633)
6. Kahn S. E., The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003 46 1 3 19 2-s2.0-0037283601 (Pubitemid 36237741)
7. Facchini F., Chen Y.-D. I., Hollenbeck C. B., Reaven G. M., Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. Journal of the American Medical Association 1991 266 21 3008 3011 2-s2.0-0026325211 10.1001/jama.266.21.3008
8. Tsouli S. G., Liberopoulos E. N., Mikhailidis D. P., Athyros V. G., Elisaf M. S., Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism: Clinical and Experimental 2006 55 10 1293 1301 2-s2.0-33748477254 10.1016/j.metabol.2006.05.013 (Pubitemid 44354944)
9. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 2007 30 1, supplement S42 S47
10. Stácaková A., Javorský M., Kuulasmaa T., Haffner S. M., Kuusisto J., Laakso M., Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 finnish men. Diabetes 2009 58 5 1212 1221 2-s2.0-65549163338 10.2337/db08-1607
11. Matsuda M., DeFronzo R. A., Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999 22 9 1462 1470 2-s2.0-0032821965 10.2337/diacare.22.9.1462 (Pubitemid 29418240)
12. Matthews D. R., Hosker J. P., Rudenski A. S., Homeostasis model assessment: insulin resistance and β -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 7 412 419 2-s2.0-0021813187 (Pubitemid 15018832)
13. Retnakaran R., Shen S., Hanley A. J., Vuksan V., Hamilton J. K., Zinman B., Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity 2008 16 8 1901 1907 2-s2.0-48749131707 10.1038/oby.2008.307
14. Weyer C., Bogardus C., Mott D. M., Pratley R. E., The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. Journal of Clinical Investigation 1999 104 6 787 794 2-s2.0-0032742992 (Pubitemid 29536364)
15. Kahn S. E., Clinical, review 135: the importance of β -cell failure in the development and progression of type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2001 86 9 4047 4058 2-s2.0-0034853485 10.1210/jc.86.9.4047 (Pubitemid 32848511)
16. United Kingdom Prospective Diabetes Study Group, U.K. Prospective Diabetes Study 16. Overview of 6 years therapy of type II diabetes: a progressive disease. Diabetes 1995 44 11 1249 1258
17. del Prato S., Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies. Diabetic Medicine 2009 26 12 1185 1192 2-s2.0-70549113397 10.1111/j.1464-5491. 2009.02847.x
18. Donath M. Y., Gross D. J., Cerasi E., Kaiser N., Hyperglycemia-induced β -cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 1999 48 4 738 744 2-s2.0-0033034807 (Pubitemid 29153072)
19. Maedler K., Spinas G. A., Dyntar D., Moritz W., Kaiser N., Donath M. Y., Distinct effects of saturated and monounsaturated fatty acids on β -cell turnover and function. Diabetes 2001 50 1 69 76 2-s2.0-0035156817 (Pubitemid 32047983)
20. Choi H. K., Mount D. B., Reginato A. M., Pathogenesis of gout. Annals of Internal Medicine 2005 143 7 499 516 2-s2.0-25644447521 (Pubitemid 41379398)
21. Cappuccio F. P., Strazzullo P., Farinaro E., Trevisan M., Uric acid metabolism and tubular sodium handling: results from a population-based study. Journal of the American Medical Association 1993 270 3 354 359 2-s2.0-0027163031 10.1001/jama.270.3.354 (Pubitemid 23202684)
22. Modan M., Halkin H., Karasik A., Lusky A., Elevated serum uric acid-a facet of hyperinsulinaemia. Diabetologia 1987 30 9 713 718 2-s2.0-0023264787 (Pubitemid 17155777)
23. Nakagawa T., Hu H., Zharikov S., Tuttle K. R., Short R. A., Glushakova O., Ouyang X., Feig D. I., Block E. R., Herrera-Acosta J., Patel J. M., Johnson R. J., A causal role for uric acid in fructose-induced metabolic syndrome. American Journal of Physiology. Renal Physiology 2006 290 3 F625 F631 2-s2.0-33645560926 10.1152/ajprenal.00140.2005 (Pubitemid 43724964)
24. Baldus S., Köster R., Chumley P., Heitzer T., Rudolph V., Ostad M. A., Warnholtz A., Staude H.-J., Thuneke F., Koss K., Berger J., Meinertz T., Freeman B. A., Münzel T., Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease. Free Radical Biology and Medicine 2005 39 9 1184 1190 2-s2.0-26044463720 10.1016/j. freeradbiomed.2005.06.004 (Pubitemid 41407712)
25. Jia L., Xing J., Ding Y., Hyperuricemia causes pancreatic β -cell death and dysfunction through NF- B signaling pathway. PLoS ONE 2013 8 10 e78284
26. Cook D. G., Shaper A. G., Thelle D. S., Whitehead T. P., Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgraduate Medical Journal 1986 62 733 1001 1006 2-s2.0-0023017933 (Pubitemid 17181719)
27. Vásquez-Vivar J., Santos A. M., Junqueira V. B., Augusto O., Peroxynitrite-mediated formation of free radicals in human plasma: EPR detection of ascorbyl, albumin-thiyl and uric acid-derived free radicals. Biochemical Journal 1996 314 869 876 (Pubitemid 26097749)
28. Robertson A. P., Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. Journal of Biological Chemistry 2004 279 41 42351 42354 2-s2.0-5644248079 10.1074/jbc.R400019200 (Pubitemid 39372114)
29. Zhang Y., Yamamoto T., Hisatome I., Uric acid induces oxidative stress and growth inhibition by activating adenosine monophosphate-activated protein kinase and extracellular signal-regulated kinase signal pathways in pancreatic β cells. Molecular and Cellular Endocrinology 2013 375 1-2 89 96
30. Nieto F. J., Iribarren C., Gross M. D., Comstock G. W., Cutler R. G., Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 2000 148 1 131 139 2-s2.0-0033990966 10.1016/S0021-9150(99) 00214-2
31. Nyyssonen K., Porkkala-Sarataho E., Kaikkonen J., Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finnish men. Atherosclerosis 1997 130 1-2 223 233 (Pubitemid 27158037)